🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas Kustermann

Roche (Switzerland)

ORCID: 0000-0003-3263-4174

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial”.

Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial

Nature Medicine(2024)10.1038/s41591-024-03270-6

N/A

0.908DataRank · unranked

51 citations

Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda, Thomas Kustermann +17 more

Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder

Brain(2025)10.1093/brain/awaf003

N/A

0DataRank · unranked

24 citations

Amélie Pelletier, Emma N. Somerville, Jacques Montplaisir, Jean‐François Gagnon, Gwendlyn Kollmorgen +6 more

Plasma Markers of Astrocytic and Axonal Integrity in Idiopathic/Isolated REM Sleep Behavior Disorder (iRBD) as Predictors of Dementia with Lewy Bodies

Movement Disorders(2025)10.1002/mds.70016

N/A

0DataRank · unranked

4 citations

Cinzia Zatti, Amélie Pelletier, J. Montplaisir, Jean‐François Gagnon, Gwendlyn Kollmorgen +5 more